癌症患者尿液2,3-吲哚醌含量的测定及其临床意义

孙伟;李冬梅;李静;李亚娟;于国英;孟德宝;岳旺

中国药学杂志 ›› 2008, Vol. 43 ›› Issue (02) : 149-151.

中国药学杂志 ›› 2008, Vol. 43 ›› Issue (02) : 149-151.
论著

癌症患者尿液2,3-吲哚醌含量的测定及其临床意义

  • 孙伟;李冬梅;李静;李亚娟;于国英;孟德宝;岳旺
作者信息 +

Determination of Urinary Isatin in Patients with Cancer and Its Clinical Significance

  • SUN Wei1,LI Dong-mei1,LI Jing1,LI Ya-juan1,YU Guo-ying1,MENG De-bao1,YUE Wang2
Author information +
文章历史 +

摘要

目的探讨癌症患者尿液2,3-吲哚醌含量测定的临床意义。方法采用高效液相色谱法测定健康志愿者及不同系统癌症患者尿液2,3-吲哚醌的含量。结果健康志愿者与胸部、泌尿系统恶性肿瘤患者尿液中2,3-吲哚醌含量有显著性差异(P<0.05);与腹部恶性肿瘤患者之间有极显著性差异(P<0.001);腹部恶性肿瘤患者分别与胸部、泌尿系统恶性肿瘤患者之间有显著性差异(P<0.05);胸部恶性肿瘤患者术前和术后7 d之间,以及不同TNM分期之间无显著性差异(P>0.05)。结论尿液2,3-吲哚醌含量可能为临床诊断癌症的检测指标。

Abstract

OBJECTIVE To develop a HPLC assay for determination of urinary isatin in cancer patients.METHODS The urinary isatin in 55 malignant tumor patients and 15 healthy volunteers were determined by HPLC.RESULTS The isatin quantification in cancer group,especially the abdominal cancer was significantly higher than that of control group(P<0.05,P<0.001).The isatin concentration in patients with abdominal cancer group,was significantly higher than that of patients with thoracic or urinary cancer.For thoracic cancer patients,there was no significant difference in isatin concentration in urine between before are after operation,and among different TNM stages.CONCLUSION The isatin concentration of urine might serve as a novel tumor diagnosis marker.

关键词

2 / 3-吲哚醌 / 尿液 / 癌症 / 高效液相色谱法

Key words

isatin / urine / cancer / HPLC

引用本文

导出引用
孙伟;李冬梅;李静;李亚娟;于国英;孟德宝;岳旺. 癌症患者尿液2,3-吲哚醌含量的测定及其临床意义[J]. 中国药学杂志, 2008, 43(02): 149-151
SUN Wei;LI Dong-mei;LI Jing;LI Y-jun;YU Guo-ying;MENG De-o;YUE Wng. Determination of Urinary Isatin in Patients with Cancer and Its Clinical Significance [J]. Chinese Pharmaceutical Journal, 2008, 43(02): 149-151

参考文献

[1] KAMINSKI K A,BODZIONY J,KOZIELSKI J . Monitoring treatment of pulmonary carcinomas by serial determination of monoamine oxidase and diamine oxidase in blood serum[J] .Arch Geschwulstforsch,1984,54(5):377-385. [2] GLOVER V,REVELEY M A,SANDLER M. A monoamine oxidase inhibitor inhuman urine[J] . Biochem Pharmacol,1980,29(3):467-470. [3] LI J,SUN W,LI Y J,et al.Study on isatin in urine as the marker of parkinson’s disease[J] .Chin Pharm J(中国药学杂志),2004,39(10):776-778. [4] GERLACH M,DESSER H,YHOUDIM M B,et al.New horizons in molecular echanisms underlying Parkinson'd isease and in our understanding of the neyroprotective effects of selegine[J] . Neurol Transm,1996,48:7-9. [5] CUI X,ZHANG B W,LI W B,et al. The antioxidative effect of monoamine oxidase B inhibitors on aging model mice induced by D galactose[J] .Chin J Psychiatry(中华精神科杂志),1999,32(3):139-141.

33

Accesses

0

Citation

Detail

段落导航
相关文章

/